Insider Trades - VANLENT ANNE

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

VANLENT ANNE: Declared Holdings
Company/Relationship	Reported	Shares	Ownership
Barrier Therapeutics, Inc. Officer NasdaqGM:BTRX (historical quotes, other insiders)	14-Mar-08	147,852	Direct
Penwest Pharmaceuticals Co. Director NasdaqGM:PPCO (historical quotes, profile, SEC, other insiders)	6-Nov-08	44,412	Direct

Insider & restricted shareholder transactions reported over the last two years
Date Shares Stock Transaction
6-Nov-08 6,900 PPCO Sale at $1.01 per share.
(Proceeds of $6,969)
14-Mar-08 10,000 BTRX Acquisition (Non Open Market) at $3.35 per share.
(Value of $33,500)
2-Jan-08 6,000 PPCO Acquisition (Non Open Market) at $0 per share.

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.
Questions or Comments?

Insider & restricted shareholder transactions reported over the last two years
Date	Shares	Stock	Transaction
6-Nov-08	6,900	PPCO	Sale at $1.01 per share. (Proceeds of $6,969)
14-Mar-08	10,000	BTRX	Acquisition (Non Open Market) at $3.35 per share. (Value of $33,500)
2-Jan-08	6,000	PPCO	Acquisition (Non Open Market) at $0 per share.